Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiprodil in Drug-Resistant Infantile Spasms
NCT02829827Phase 2Terminated
- Sponsor
- UCB
- Start
- Dec 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of radiprodil in infantile epileptic spasms syndrome (IESS), sponsored by UCB. Started Dec 2017; status: terminated.
02
Drugs
radiprodil
03
Conditions
infantile epileptic spasms syndrome (IESS)
Beyond the preview
Go deeper on NCT02829827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02829827.